Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Video: Antibody drug–conjugates characterization (Waters Corporation)

21 May 2015
Chromatography MS (LC–MS/MS, HRMS, IMS)

This video discusses powerful analytical tools which can be used to interrogate and understand ADCs. In particular, it outlines:

  • Characterizing ADCs with hydrophobic interaction chromatography
  • Deriving DAR via native UPLC/MS
  • Resolving positional isomers by 2D UPLC/MS
  • Identifying conjugation by peptide mapping

Top content

  • Driving innovation in clinical research: a look inside Worldwide’s large molecule lab
  • Thermo Fisher’s NGS assay receives FDA approval
  • Major M&A deals impacting bioanalysis in 2025

Related tags

ADCs LC-MS MS
Previous article Next article

Related articles

15 JUL 2013 NEWS
Aberrant glycans demonstrate promise as disease biomarkers
30 NOV 2010 COLLABORATIONS AND MERGERS
2010 White Paper on Recent Issues in Regulated Bioanalysis & Global Harmonization of Bioanalytical Guidance
13 APR 2015 GENERAL INTEREST
Video: Announcing SWATH™ Acquisition 2.0 (SCIEX)
14 DEC 2017 BIOMARKERS
A novel and non-invasive approach to drug and disease detection
4 APR 2024 JOURNAL ARTICLES
Validation of Mitra® VAMS® as a blood collection technique for trace elements analysis using ICP-MS/MS
1 OCT 2020 JOURNAL ARTICLES
Crucial importance of evaluating internal standards (IS) response and troubleshooting in effective LCMS method development, validation and sample analysis
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone